| Time | Session |
|---|
|
9:45 a.m.
10:03 a.m.
|
What Have We Learned From CONVINCE?
PeterBlankestijn
Oral Abstract Presenter
P.J.Blankestijn@umcutrecht.nlUniversity Medical Center UtrechtNetherlands
|
|
10:03 a.m.
10:21 a.m.
|
Design of the ZEUS Trial: Interleukin-6 Inhibition With Ziltivekimab for Cardiovascular Protection in Chronic Kidney Disease
VladoPerkovic
Oral Abstract Presenter
vlado.perkovic@unsw.edu.auUniversity of New South Wales, Sydney, AustraliaAustralia
|
|
10:23 a.m.
10:41 a.m.
|
A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)
|
|
10:41 a.m.
10:59 a.m.
|
Observational Cohort With Embedded Randomized Controlled Trials to Study Pregnancy-Associated Progression of Renal Disease: A Feasibility Study of Dietary Nitrate (Beetroot Juice) to Protect Kidney Function in Pregnant Women With Chronic Kidney Disease
PriscillaSmith
Oral Abstract Presenter
priscilla.smith@kcl.ac.ukKings College Hospital LondonUnited Kingdom
|
|
10:59 a.m.
11:15 a.m.
|
Design of Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-Proven Primary Glomerular Diseases: Multi-Center, Multi-Arm and Multi-Stage
|